| P2093 | author name string | Andreas M Kaufmann | |
| | Rosemarie Preyer | |
| | Matthias Hempel | |
| | Aleksandra Pesic | |
| | Amrei Krings | |
| | Carola Schreckenberger | |
| P2860 | cites work | The causal relation between human papillomavirus and cervical cancer | Q24673148 |
| | Classification of papillomaviruses | Q29618731 |
| | Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype | Q33218333 |
| | Bead-based multiplex genotyping of human papillomaviruses | Q34430808 |
| | Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control | Q35036033 |
| | Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers | Q36497937 |
| | Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases | Q36584410 |
| | Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening | Q36616805 |
| | Cervical cancer screening in the 21st century: is it time to retire the PAP smear? | Q36827011 |
| | Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries | Q37291430 |
| | Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older | Q37461977 |
| | Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study | Q37546177 |
| | Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials | Q38160099 |
| | Management of women with human papillomavirus persistence: long-term follow-up of a randomized clinical trial. | Q40459247 |
| | Natural history of cervicovaginal papillomavirus infection in young women. | Q50909200 |
| | Human papillomavirus infections with multiple types and risk of cervical neoplasia. | Q53612097 |
| | Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. | Q54495496 |
| | Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women | Q61755171 |
| | Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer | Q78419962 |
| | Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica | Q81714676 |
| P433 | issue | 3-4 | |
| P921 | main subject | genotyping | Q912147 |
| P304 | page(s) | 124-133 | |
| P577 | publication date | 2019-09-05 | |
| P1433 | published in | Intervirology | Q15757002 |
| P1476 | title | Analytical Evaluation of the Human Papillomavirus HPV DNA Array E1-Based Genotyping Assay | |
| P478 | volume | 62 | |